Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Any Hope for Relief from PAMA Medicare Price Cuts?

It is a notable and rare success for the clinical laboratory profession to convince the House and Senate to pass a law that is favorable to the interests of patients and the clinical laboratories that serve them. Yet that is what happened when Congress passed the Laboratory Access for Beneficiaries (LAB) Act in December and …

Any Hope for Relief from PAMA Medicare Price Cuts? Read More »

To access this post, you must purchase The Dark Report.

Comments

;